Virginia Tech is a public land-grant research university with its main campus in Blacksburg, Virginia. It also has educational facilities in six regions statewide, a research center in Punta Cana, Dominican Republic, and a study-abroad site in Riva San Vitale, Switzerland.

During the past decade, Virginia Polytechnic Institute and State University conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 1 clinical trials were completed, i.e. on average, 5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Polytechnic Institute and State University" #1 sponsor was "Virginia Polytechnic Institute and State University" with 21 trials, followed by "Edward Via Virginia College of Osteopathic Medicine" with 1 trials sponsored, "Karen Roberto" with 1 trials sponsored, "Kevin Davy" with 1 trials sponsored and "Mark Dignan, PhD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Polytechnic Institute and State University" #1 collaborator was "Duke University" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "American Diabetes Association" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Polytechnic Institute and State University" are "Cardiovascular Risk Factor" (4 trials), "Insulin Sensitivity" (3 trials), "Continuous Glucose Monitoring" (2 trials), "Diabetes" (2 trials) and "Inflammatory Markers" (2 trials). Many other conditions were trialed in "Virginia Polytechnic Institute and State University" in a lesser frequency.

Most popular intervention types in "Virginia Polytechnic Institute and State University" are "Other" (10 trials), "Behavioral" (9 trials), "Dietary Supplement" (7 trials), "Procedure" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Choline" (2 trials), "No UPF controlled diet" (2 trials), "Non-Nutritive Sweetener Intake and impact on glucose homeostasis" (2 trials) and "Choline capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Polytechnic Institute and State University" are 24 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Polytechnic Institute and State University". 2 are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Virginia Polytechnic Institute and State University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Polytechnic Institute and State University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 22 trials that are defined as “Not Applicable".